Related references
Note: Only part of the references are listed.Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide
Cecilia Cheng-Mayer et al.
AIDS (2011)
Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination
Susan M. Schader et al.
AIDS (2011)
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
Morgane Bomsel et al.
IMMUNITY (2011)
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc
Claire J. Forbes et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
Salim S. Abdool Karim et al.
LANCET (2011)
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
L. A. Lagenaur et al.
MUCOSAL IMMUNOLOGY (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Turning the Tide Against HIV
Robin J. Shattock et al.
SCIENCE (2011)
Identification of Rhesus Macaque Genital Microbiota by 16S Pyrosequencing Shows Similarities to Human Bacterial Vaginosis: Implications for Use as an Animal Model for HIV Vaginal Infection
Gregory T. Spear et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV-1 Entry via the CCR5 Co-Receptor
Ronald S. Veazey et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis
Virginie Supervie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women
Annalene Nel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates
Nattawan Promadej-Lanier et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2009)
A piece de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
John P. Moore et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission
Per Johan Masse et al.
ANNUAL REVIEW OF MEDICINE (2008)
Maraviroc: The first of a new class of antiretroviral agents
Rodger D. MacArthur et al.
CLINICAL INFECTIOUS DISEASES (2008)
Perspective - Whither or wither microbicides?
Robert M. Grant et al.
SCIENCE (2008)
Entry inhibitor-based microbicides are active in vitro against HTV-1 isolates from multiple genetic subtypes
Thomas J. Ketas et al.
VIROLOGY (2007)
Which topical microbicides for blocking HIV-1 transmission will work in the real world?
Per Johan Klasse et al.
PLOS MEDICINE (2006)
Microbicides and other topical strategies to prevent vaginal transmission of HIV
MM Lederman et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Microbicides to prevent HIV transmission: Overcoming obstacles to chemical barrier protection
D Dhawan et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human
C Napier et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion
RS Veazey et al.
NATURE (2005)
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
RK Malcolm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1
G Fätkenheuer et al.
NATURE MEDICINE (2005)
Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera®
J Jain et al.
CONTRACEPTION (2004)
Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs
C Seibert et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Inhibiting sexual transmission of HIV-1 infection
RJ Shattock et al.
NATURE REVIEWS MICROBIOLOGY (2003)
Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings
K Malcolm et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
Microbicides: A new approach to preventing HIV and other sexually transmitted infections
A Stone
NATURE REVIEWS DRUG DISCOVERY (2002)
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV
JA Turpin
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora
DA Eschenbach et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
